Want to join the conversation?
Medical technology company $SYK posted higher 1Q16 net income of $402MM or $1.07 per diluted share vs. $$224MM or $0.58 per diluted share in 1Q15, helped by higher earnings before income taxes. Net sales were $2.5Bil, up 4.9% as reported and 6.1% in constant currency, as foreign currency exchange rates negatively impacted net sales by 1.3%.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)